191 related articles for article (PubMed ID: 31610219)
1. Characterization and protective efficacy of a Salmonella pathogenicity island 2 (SPI2) mutant of Salmonella Paratyphi A.
Yin J; Cheng Z; Wu Y; He Q; Zhang J; Yang Z; Ding S; Li J; Guo D
Microb Pathog; 2019 Dec; 137():103795. PubMed ID: 31610219
[TBL] [Abstract][Full Text] [Related]
2. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
[TBL] [Abstract][Full Text] [Related]
3. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.
Gat O; Galen JE; Tennant S; Simon R; Blackwelder WC; Silverman DJ; Pasetti MF; Levine MM
PLoS Negl Trop Dis; 2011 Nov; 5(11):e1373. PubMed ID: 22069504
[TBL] [Abstract][Full Text] [Related]
4. Characterization and protective efficacy of a sptP mutant of Salmonella Paratyphi A.
Pan P; Zou F; He C; He Q; Yin J
Immun Inflamm Dis; 2020 Dec; 8(4):774-781. PubMed ID: 33135379
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
6. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
7. Attenuated
Liu Q; Li P; Luo H; Curtiss R; Kong Q
Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
[No Abstract] [Full Text] [Related]
8. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
9. Expression of Concern: Cell-Associated Flagella Enhance the Protection Conferred by Mucosally-Administered Attenuated Salmonella Paratyphi A Vaccines.
PLOS Neglected Tropical Diseases Editors
PLoS Negl Trop Dis; 2024 May; 18(5):e0012160. PubMed ID: 38709719
[No Abstract] [Full Text] [Related]
10. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
[TBL] [Abstract][Full Text] [Related]
11. Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates.
Roland KL; Tinge SA; Kochi SK; Thomas LJ; Killeen KP
Vaccine; 2010 May; 28(21):3679-87. PubMed ID: 20338215
[TBL] [Abstract][Full Text] [Related]
12. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Salmonella enterica Serovar Pullorum Pathogenicity Island 2 Mutant as a Candidate Live Attenuated Oral Vaccine.
Yin J; Cheng Z; Wang X; Xu L; Li Q; Geng S; Jiao X
Clin Vaccine Immunol; 2015 Jul; 22(7):706-10. PubMed ID: 25924763
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
Pakkanen SH; Kantele JM; Kantele A
Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
[TBL] [Abstract][Full Text] [Related]
15. Improving Our Understanding of
Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of chickens with Salmonella Pathogenicity Island (SPI) 1 and SPI2 defective mutants of Salmonella enterica serovar Enteritidis.
Matulova M; Havlickova H; Sisak F; Rychlik I
Vaccine; 2012 Mar; 30(12):2090-7. PubMed ID: 22300724
[TBL] [Abstract][Full Text] [Related]
17. [The anti-Salmonella paratyphi B vaccination].
Dimache G; Vlădoianu IR; Dimache V; Popescu P; Antonescu O; Mitrea D
Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):477-86. PubMed ID: 4999244
[No Abstract] [Full Text] [Related]
18. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
[TBL] [Abstract][Full Text] [Related]
19. Syntheses of Salmonella Paratyphi A Associated Oligosaccharide Antigens and Development towards Anti-Paratyphoid Fever Vaccines.
Dhara D; Baliban SM; Huo CX; Rashidijahanabad Z; Sears KT; Nick ST; Misra AK; Tennant SM; Huang X
Chemistry; 2020 Dec; 26(68):15953-15968. PubMed ID: 32578281
[TBL] [Abstract][Full Text] [Related]
20. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
